HIGHFDA DEVICE

BioFire Defense FilmArray NGDS Warrior Panel NGDS-ASY-0007 Recall 130 Kits in 2025

BioFire Defense recalled 130 FilmArray NGDS Warrior Panel NGDS-ASY-0007 kits distributed nationwide in the United States. The recall cites an increased risk of internal control failures when testing positive blood cultures. Clinicians should stop using the device immediately and follow recall instructions provided by BioFire Defense. Notification is by letter to affected facilities.

Official notice
BioFire DefenseHealth & Personal CareMedical DevicesNGDS-ASY-0007UDI-DI: 00851458005136

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
July 10, 2025
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
July 10, 2025
Hazard Level
HIGH
Brand
BioFire Defense
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
BioFire Defense
Product type
In Vitro Diagnostic Test
Model numbers
NGDS-ASY-0007, UDI-DI: 00851458005136
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    July 10, 2025

  2. Reported by FDA DEVICE

    October 1, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

FilmArray NGDS Warrior Panel (NGDS-ASY-0007) has an increased risk of internal control failures when testing positive blood culture, which may lead to delayed results and additional diagnostic workup.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Biofire Defense or your healthcare provider for instructions. Notification method: Letter

About This Product

The FilmArray NGDS Warrior Panel is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test used with the FilmArray 2.0 system. It is designed to rapidly identify pathogens in positive blood culture specimens.

Why This Is Dangerous

An increased risk of internal control failures may cause false or delayed test results, potentially delaying diagnosis and appropriate treatment.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Delays in diagnostic results can affect patient management and hospital workflow, potentially extending hospital stays and delaying targeted therapies.

Practical Guidance

How to identify if yours is affected

  1. Confirm kit is NGDS Warrior Panel NGDS-ASY-0007 by checking model number on the packaging and device.
  2. Verify UDI-DI 00851458005136 on the label.

Where to find product info

Recall notices are issued via letter and posted on FDA enforcement pages. Look for the recall number Z-2609-2025 on official notices.

What timeline to expect

Replacement or refund processing typically follows the notification timeline set by BioFire Defense; expect 4-6 weeks for processing after submission.

If the manufacturer is unresponsive

  • Escalate to hospital compliance or biosafety officer.
  • Consider contacting regulatory authorities if the company is non-responsive.

How to prevent similar issues

  • Verify device recalls before placing orders.
  • Keep an updated inventory of all diagnostic kits with lot numbers and UDI-DI.
  • Establish a clear line of communication with suppliers for recall handling.

Documentation advice

Document notification date, kit lot numbers, UDI-DI, and all communications with BioFire Defense. Retain packaging and labeling for verification.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • NAS distribution across AL, AZ, UT, CA, TX, DC, VA, FL, MD, OH, HI, NY, KY, LA, MA, MI, MN, MO, NC,
  • NH, RI, NV, TN, IA, WA

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
NGDS-ASY-0007
UDI-DI: 00851458005136
Affected States
ALL
Report Date
October 1, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more